SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Divis Laboratories
Divis Laboratories
BSE: 532488|NSE: DIVISLAB|ISIN: INE361B01024|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 21, 16:15
1736.65
-0.45 (-0.03%)
VOLUME 6,330
LIVE
NSE
Nov 21, 16:15
1737.70
-1.7 (-0.1%)
VOLUME 77,085
News on Divis Laboratories
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Divis Labs: Manoj Murlidharan 

12.12 pm | 13 Nov 2014 |  Source: CNBC-TV18

Manoj Murlidharan of Religare Securities recommends buying Divis Laboratories....

Buy Hero Motocorp, Divis Labs, Ambuja Cements: Sukhani 

3.29 pm | 12 Nov 2014 |  Source: Moneycontrol.com

Sudarshan Sukhani of s2analytics.com recommends buying Hero Motocorp, Divis Laboratories and Ambuja Cements....

Top 10 stocks to keep an eye on November 3 

8.43 am | 03 Nov 2014 |  Source: CNBC-TV18

Here are Top 10 stocks to focus on November 3 - Tata Steel, GAIL, Spicejet, Jet Air, M&M, Tata Motors, Maruti, Karnataka Bank, Divi's Labs, DCB....

Stocks in news: Tata Motors, Maruti, NMDC, IOC, JSW Energy

8.30 am | 03 Nov 2014 |  Source: CNBC-TV18

Tata Motors | M&M | NMDC | Karnataka Bank | JSW Energy | Cairn India | Ranbaxy Labs | JSW Steel | IOC | Bank of India | Dabur | GVK Power | Tata Comm ...

Buy Divis Laboratories, advises Sudarahan Sukhani 

10.51 am | 30 Oct 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends buying Divis Laboratories....

Market to conquer 8200 in early Nov series: Sukhani 

9.25 am | 30 Oct 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics believes the market is in an on-going momentum driven uptrend and it is likely to take out 8200 in early part of Nove...

Buy Divis Laboratories, says Hemant Thukral 

11.50 am | 27 Oct 2014 |  Source: CNBC-TV18

According to Hemant Thukral of Aditya Birla Money, one may buy Divis Laboratories. It may retest Rs 1,870-1,880....

Prefer Axis Bank, Wipro, Divis Labs: Phani Sekhar 

4.24 pm | 22 Oct 2014 |  Source: CNBC-TV18

P Phani Sekhar, Fund Manager, PMS at Angel Broking is of the view that one may prefer Divis Labs, Wipro, Hindustan Media Ventures, Indiabulls Housing ...

Prefer Divis Laboratories, says Sudarshan Sukhani 

10.30 am | 16 Oct 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one may prefer Divis Laboratories....

Buy on dips, but manage your risks well: Sukhani 

9.29 am | 16 Oct 2014 |  Source: CNBC-TV18

According to Sudarshan Sukhani, though it could be difficult for markets to move up due to lack of favourable factors, a good amount of buying interes...

Buy Divis Labs; target of Rs 1795: ICICIdirect

2.42 pm | 25 Aug 2014 |  Source: Moneycontrol.com

ICICIdirect.com is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 1795 in its August 25, 2014 research ...

Buy Divis Labs; target of Rs 1633: ICICIdirect

2.45 pm | 21 Aug 2014 |  Source: Moneycontrol.com

ICICIdirect.com is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 1633 in its August 15, 2014 research ...

Hold Divis Laboratories; target of Rs 1430: Emkay

2.43 pm | 13 Aug 2014 |  Source: Moneycontrol.com

Emkay Global Financial Services has recommended hold rating on Divis Laboratories with a target price of Rs 1430, in its research report dated August ...

Buy Divis Labs; target of Rs 1425: ICICIdirect

12.27 pm | 28 May 2014 |  Source: Moneycontrol.com

ICICIdirect.com is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 1425 in its May 27, 2014 research rep...

Buy Divis Laboratories; target of Rs 1419: Emkay

11.05 am | 28 May 2014 |  Source: Moneycontrol.com

Brokerage house Emkay Global Financial Services is bullish on Divis Laboratories and has recommended buy rating on the stock with a target price of Rs...

Divis Labs consolidated Mar '14 sales at Rs 750.21 crore

2.05 pm | 27 May 2014 |  Source: Moneycontrol.com

Divis Laboratories has reported a sales turnover of Rs 750.21 crore and a net profit of Rs 196.43 crore for the quarter ended Mar '14...

Buy Divis Laboratories; target of Rs 1500: Sharekhan

11.57 am | 27 May 2014 |  Source: Moneycontrol.com

Sharekhan is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 1500 in its May 26, 2014 research report....

Accumulate Divis Labs; target of Rs 1483: Dolat Capital

5.02 pm | 26 May 2014 |  Source: Moneycontrol.com

Dolat Capital is bullish on Divis Laboratories and has recommended accumulate rating on the stock with a target of Rs 1483 in its May 26, 2014 researc...

Buy Divis Labs; target of Rs 1484: Karvy Stock Broking

12.37 pm | 26 May 2014 |  Source: Moneycontrol.com

Karvy Stock Broking is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 1484 in its May 26, 2014 research...

1 2 3
Quick Links for Divis Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.